You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Baxter
Moodys
McKinsey
Dow

Last Updated: March 9, 2021

DrugPatentWatch Database Preview

Vancomycin hydrochloride - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for vancomycin hydrochloride and what is the scope of patent protection?

Vancomycin hydrochloride is the generic ingredient in seven branded drugs marketed by Ani Pharms Inc, Akorn, Fresenius Kabi Usa, Lupin Ltd, Orient Pharma Co Ltd, Strides Pharma, Watson Labs, Azurity, Lederle, Baxter Hlthcare, West-ward Pharms Int, Aurobindo Pharma Ltd, Emcure Pharms Ltd, Gland Pharma Ltd, Hainan Poly Pharm, Hikma, Hikma Pharms, Hospira, Hospira Inc, Mylan Labs Ltd, Pharm Assoc, Sagent Pharms, Sandoz, Sandoz Inc, Teva Pharms Usa, Xellia Pharms Aps, Pharmacia And Upjohn, and Samson Medcl, and is included in fifty-two NDAs. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Vancomycin hydrochloride has thirty-six patent family members in twenty-five countries.

There are twenty-two drug master file entries for vancomycin hydrochloride. Twenty-five suppliers are listed for this compound.

Summary for vancomycin hydrochloride
International Patents:36
US Patents:5
Tradenames:7
Applicants:28
NDAs:52
Drug Master File Entries: 22
Suppliers / Packagers: 25
Bulk Api Vendors: 63
Clinical Trials: 366
Patent Applications: 1,725
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in vancomycin hydrochloride?vancomycin hydrochloride excipients list
DailyMed Link:vancomycin hydrochloride at DailyMed
Recent Clinical Trials for vancomycin hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Joint Purification SystemsPhase 3
National Cancer Institute (NCI)Early Phase 1
M.D. Anderson Cancer CenterEarly Phase 1

See all vancomycin hydrochloride clinical trials

Pharmacology for vancomycin hydrochloride
Medical Subject Heading (MeSH) Categories for vancomycin hydrochloride
Paragraph IV (Patent) Challenges for VANCOMYCIN HYDROCHLORIDE
Tradename Dosage Ingredient NDA Submissiondate
FIRVANQ KIT FOR SOLUTION;ORAL vancomycin hydrochloride 208910 2020-05-18

US Patents and Regulatory Information for vancomycin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lederle VANCOLED vancomycin hydrochloride FOR SOLUTION;ORAL 063321-002 Oct 15, 1993 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs VANCOMYCIN HYDROCHLORIDE vancomycin hydrochloride CAPSULE;ORAL 065510-001 Apr 9, 2012 AB RX No No   Start Trial   Start Trial   Start Trial
Ani Pharms Inc VANCOCIN HYDROCHLORIDE vancomycin hydrochloride INJECTABLE;INJECTION 062716-001 Mar 13, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Xellia Pharms Aps VANCOMYCIN HYDROCHLORIDE vancomycin hydrochloride SOLUTION;INTRAVENOUS 211962-006 May 13, 2020 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Fresenius Kabi Usa VANCOMYCIN HYDROCHLORIDE vancomycin hydrochloride INJECTABLE;INJECTION 062663-002 Jul 31, 1987 AP RX No Yes   Start Trial   Start Trial   Start Trial
Azurity FIRVANQ KIT vancomycin hydrochloride FOR SOLUTION;ORAL 208910-001 Jan 26, 2018 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Emcure Pharms Ltd VANCOMYCIN HYDROCHLORIDE vancomycin hydrochloride INJECTABLE;INJECTION 202274-001 Oct 31, 2013 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
McKesson
Colorcon
Dow
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.